Elevated methylation of Sp1 inhibited the expression level of Sp1 and subsequently inhibited the proliferation of HNSCC cells, suggesting that Sp1 methylation might as a molecular indicator of malignant cell growth. This evidence concerns the gene SP1 and head and neck squamous cell carcinoma.